High burden of Carbapenem-resistant Enterobacteriaceae (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting
Open Access
- 2 May 2017
- journal article
- research article
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 6 (1) , 42
Abstract
Infections by multidrug-resistant gram-negative bacteria (MDR-GNB) have been continuously growing and pose challenge to health institution globally. Carbapenem-resistant Enterobacteriacea (CRE) was identified as one of the MDR-GNB which has limited treatment options and higher mortality compared to those of sensitive strains. We report an increased burden of CRE fecal carriage at a hospital in the North-eastern region of Malaysia. A retrospective descriptive study from August 2013 to December 2015 was conducted in the Medical Microbiology & Parasitology laboratory of Hospital Universiti Sains Malaysia, which is a tertiary teaching hospital with more than 700 beds. This hospital treats patients with various medical and surgical conditions. Suspected CRE from any clinical specimens received by the laboratory was identified and confirmed using standard protocols. Polymerase chain reaction (PCR) assay was performed to determine the genotype. Altogether, 8306 Enterobacteriaceae was isolated from various clinical specimens during the study period and 477/8306 (5.74%) were CRE. Majority of the isolated CRE were Klebsiella [408/477, (85.5%)], of which Klebsiella pneumoniae was the predominant species, 388/408 (95%). CRE were mainly isolated from rectal swab (screening), 235/477 (49.3%); urine, 76/477 (15.9%); blood, 46/477 (9.6%) and about 7.1% from tracheal aspirate. One hundred and thirty-six isolates were subjected to genotype determination and., 112/136 (82.4%) showed positive detection of New Delhi metallo-β-lactamase 1 (NDM-1) gene (bla NDM1). The study noted a high numbers of CRE isolated especially from rectal swabs. Active screening results in significant cost pressures and therefore should be revisited and revised, especially in low resource settings.Keywords
This publication has 23 references indexed in Scilit:
- Costs and possible benefits of a two-tier infection control management strategy consisting of active screening for multidrug-resistant organisms and tailored control measuresJournal of Hospital Infection, 2016
- Epidemiology and molecular characterization of multidrug-resistant Gram-negative bacteria in Southeast AsiaAntimicrobial Resistance & Infection Control, 2016
- Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working PartyJournal of Hospital Infection, 2016
- Molecular detection of the New Delhi metallo-β-lactamase-1 gene in Enterobacteriaceae isolates in a tertiary medical centre.2015
- Detection of blaIMP4 and blaNDM1 harboring Klebsiella pneumoniae isolates in a university hospital in MalaysiaEmerging Health Threats Journal, 2015
- A hospital-based matched case–control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infectionBMC Infectious Diseases, 2013
- The Global Spread of Healthcare-Associated Multidrug-Resistant Bacteria: A Perspective From AsiaClinical Infectious Diseases, 2013
- Rectal Screening for Klebsiella pneumoniae Carbapenemases: Comparison of Real-Time PCR and Culture Using Two Selective Screening Agar PlatesJournal of Clinical Microbiology, 2012
- Costs of Healthcare- and Community-Associated Infections With Antimicrobial-Resistant Versus Antimicrobial-Susceptible OrganismsClinical Infectious Diseases, 2012
- Management of multidrug-resistant organisms in health care settings, 2006American Journal of Infection Control, 2007